{"organizations": [], "uuid": "a31caad9d9a8f39ca51cadde95ec229fc5310394", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180521.html", "section_title": "Archive News &amp; Video for Monday, 21 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fda-approves-dova-pharmas-new-drug/brief-fda-approves-dova-pharmas-new-drug-for-patients-with-cld-who-have-low-blood-platelets-idUSFWN1SS0PB", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Approves Dova Pharma's New Drug For Patients With CLD Who Have Low Blood Platelets", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.714, "site_type": "news", "published": "2018-05-21T23:58:00.000+03:00", "replies_count": 0, "uuid": "a31caad9d9a8f39ca51cadde95ec229fc5310394"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fda-approves-dova-pharmas-new-drug/brief-fda-approves-dova-pharmas-new-drug-for-patients-with-cld-who-have-low-blood-platelets-idUSFWN1SS0PB", "ord_in_thread": 0, "title": "BRIEF-FDA Approves Dova Pharma's New Drug For Patients With CLD Who Have Low Blood Platelets", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-fda approves dova pharma", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 21 (Reuters) - U.S. FDA:\n* FDA APPROVES NEW DRUG FOR PATIENTS WITH CHRONIC LIVER DISEASE WHO HAVE LOW BLOOD PLATELETS AND ARE UNDERGOING A MEDICAL PROCEDURE\n* FDA SAYS THE FDA GRANTED THE APPROVAL TO AKARX INC Source text ( bit.ly/2KJdLPc ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "http://bit.ly/2KJdLPc", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-21T23:58:00.000+03:00", "crawled": "2018-05-22T19:28:17.000+03:00", "highlightTitle": ""}